Bovine Colostrum Supplementation Improves Bone Metabolism in an Osteoporosis-Induced Animal Model

Osteoporosis is characterized by bone loss. The present study aims to investigate the effects of bovine colostrum (BC) on bone metabolism using ovariectomized (OVX) and orchidectomized (ORX) rat models. Twenty-seven-week-old Wistar Han rats were randomly assigned as: (1) placebo control, (2) BC supp...

Full description

Bibliographic Details
Main Authors: Eirini K. Kydonaki, Laura Freitas, Bruno M. Fonseca, Henrique Reguengo, Carlos Raposo Simón, Ana R. Bastos, Emanuel M. Fernandes, Raphaël F. Canadas, Joaquim Miguel Oliveira, Vitor M. Correlo, Rui L. Reis, Maria Vliora, Parakevi Gkiata, Yiannis Koutedakis, Georgia Ntina, Rui Pinto, Andres E. Carrillo, Franklim Marques, Tânia Amorim
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/13/9/2981
_version_ 1797517770513973248
author Eirini K. Kydonaki
Laura Freitas
Bruno M. Fonseca
Henrique Reguengo
Carlos Raposo Simón
Ana R. Bastos
Emanuel M. Fernandes
Raphaël F. Canadas
Joaquim Miguel Oliveira
Vitor M. Correlo
Rui L. Reis
Maria Vliora
Parakevi Gkiata
Yiannis Koutedakis
Georgia Ntina
Rui Pinto
Andres E. Carrillo
Franklim Marques
Tânia Amorim
author_facet Eirini K. Kydonaki
Laura Freitas
Bruno M. Fonseca
Henrique Reguengo
Carlos Raposo Simón
Ana R. Bastos
Emanuel M. Fernandes
Raphaël F. Canadas
Joaquim Miguel Oliveira
Vitor M. Correlo
Rui L. Reis
Maria Vliora
Parakevi Gkiata
Yiannis Koutedakis
Georgia Ntina
Rui Pinto
Andres E. Carrillo
Franklim Marques
Tânia Amorim
author_sort Eirini K. Kydonaki
collection DOAJ
description Osteoporosis is characterized by bone loss. The present study aims to investigate the effects of bovine colostrum (BC) on bone metabolism using ovariectomized (OVX) and orchidectomized (ORX) rat models. Twenty-seven-week-old Wistar Han rats were randomly assigned as: (1) placebo control, (2) BC supplementation dose 1 (BC1: 0.5 g/day/OVX, 1 g/day/ORX), (3) BC supplementation dose 2 (BC2: 1 g/day/OVX, 1.5 g/day/ORX) and (4) BC supplementation dose 3 (BC3: 1.5 g/day/OVX, 2 g/day/ORX). Bone microarchitecture, strength, gene expression of VEGFA, FGF2, RANKL, RANK and OPG, and bone resorption/formation markers were assessed after four months of BC supplementation. Compared to the placebo, OVX rats in the BC1 group exhibited significantly higher cortical bone mineral content and trabecular bone mineral content (<i>p</i> < 0.01), while OVX rats in the BC3 group showed significantly higher trabecular bone mineral content (<i>p</i> < 0.05). ORX rats receiving BC dose 2 demonstrated significantly higher levels of trabecular bone mineral content (<i>p</i> < 0.05). Serum osteocalcin in the ORX was pointedly higher in all BC supplementation groups than the placebo (BC1: <i>p</i> < 0.05; BC2, BC3: <i>p</i> < 0.001). Higher doses of BC induced significantly higher relative mRNA expression of OPG, VEGFA, FGF2 and RANKL (<i>p</i> < 0.05). BC supplementation improves bone metabolism of OVX and ORX rats, which might be associated with the activation of the VEGFA, FGF2 and RANKL/RANK/OPG pathways.
first_indexed 2024-03-10T07:20:50Z
format Article
id doaj.art-008c1b01eaf844d6ad22cbba0ea8f932
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-10T07:20:50Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-008c1b01eaf844d6ad22cbba0ea8f9322023-11-22T14:35:27ZengMDPI AGNutrients2072-66432021-08-01139298110.3390/nu13092981Bovine Colostrum Supplementation Improves Bone Metabolism in an Osteoporosis-Induced Animal ModelEirini K. Kydonaki0Laura Freitas1Bruno M. Fonseca2Henrique Reguengo3Carlos Raposo Simón4Ana R. Bastos5Emanuel M. Fernandes6Raphaël F. Canadas7Joaquim Miguel Oliveira8Vitor M. Correlo9Rui L. Reis10Maria Vliora11Parakevi Gkiata12Yiannis Koutedakis13Georgia Ntina14Rui Pinto15Andres E. Carrillo16Franklim Marques17Tânia Amorim18UCIBIO/REQUIMTE, Faculty of Pharmacy, University of Porto, 4050-313 Porto, PortugalUCIBIO/REQUIMTE, Faculty of Pharmacy, University of Porto, 4050-313 Porto, PortugalUCIBIO/REQUIMTE, Faculty of Pharmacy, University of Porto, 4050-313 Porto, PortugalUCIBIO/REQUIMTE, Faculty of Pharmacy, University of Porto, 4050-313 Porto, PortugalSALURIS, 28108 Madrid, Spain3B’s Research Group, I3Bs—Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Guimarães, Portugal3B’s Research Group, I3Bs—Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Guimarães, Portugal3B’s Research Group, I3Bs—Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Guimarães, Portugal3B’s Research Group, I3Bs—Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Guimarães, Portugal3B’s Research Group, I3Bs—Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Guimarães, Portugal3B’s Research Group, I3Bs—Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Guimarães, PortugalSchool of Sports and Exercise Sciences, University of Thessaly, 42100 Trikala, GreeceSchool of Sports and Exercise Sciences, University of Thessaly, 42100 Trikala, GreeceSchool of Sports and Exercise Sciences, University of Thessaly, 42100 Trikala, GreeceBME, Biomechanical Solutions, 43150 Karditsa, GreeceiMed.UL, Faculty of Pharmacy, University of Lisbon, 1649-003 Lisbon, PortugalDepartment of Exercise Science, Chatham University, Pittsburgh, PA 15232, USAUCIBIO/REQUIMTE, Faculty of Pharmacy, University of Porto, 4050-313 Porto, PortugalUCIBIO/REQUIMTE, Faculty of Pharmacy, University of Porto, 4050-313 Porto, PortugalOsteoporosis is characterized by bone loss. The present study aims to investigate the effects of bovine colostrum (BC) on bone metabolism using ovariectomized (OVX) and orchidectomized (ORX) rat models. Twenty-seven-week-old Wistar Han rats were randomly assigned as: (1) placebo control, (2) BC supplementation dose 1 (BC1: 0.5 g/day/OVX, 1 g/day/ORX), (3) BC supplementation dose 2 (BC2: 1 g/day/OVX, 1.5 g/day/ORX) and (4) BC supplementation dose 3 (BC3: 1.5 g/day/OVX, 2 g/day/ORX). Bone microarchitecture, strength, gene expression of VEGFA, FGF2, RANKL, RANK and OPG, and bone resorption/formation markers were assessed after four months of BC supplementation. Compared to the placebo, OVX rats in the BC1 group exhibited significantly higher cortical bone mineral content and trabecular bone mineral content (<i>p</i> < 0.01), while OVX rats in the BC3 group showed significantly higher trabecular bone mineral content (<i>p</i> < 0.05). ORX rats receiving BC dose 2 demonstrated significantly higher levels of trabecular bone mineral content (<i>p</i> < 0.05). Serum osteocalcin in the ORX was pointedly higher in all BC supplementation groups than the placebo (BC1: <i>p</i> < 0.05; BC2, BC3: <i>p</i> < 0.001). Higher doses of BC induced significantly higher relative mRNA expression of OPG, VEGFA, FGF2 and RANKL (<i>p</i> < 0.05). BC supplementation improves bone metabolism of OVX and ORX rats, which might be associated with the activation of the VEGFA, FGF2 and RANKL/RANK/OPG pathways.https://www.mdpi.com/2072-6643/13/9/2981bovine colostrumboneosteoporosissupplementation
spellingShingle Eirini K. Kydonaki
Laura Freitas
Bruno M. Fonseca
Henrique Reguengo
Carlos Raposo Simón
Ana R. Bastos
Emanuel M. Fernandes
Raphaël F. Canadas
Joaquim Miguel Oliveira
Vitor M. Correlo
Rui L. Reis
Maria Vliora
Parakevi Gkiata
Yiannis Koutedakis
Georgia Ntina
Rui Pinto
Andres E. Carrillo
Franklim Marques
Tânia Amorim
Bovine Colostrum Supplementation Improves Bone Metabolism in an Osteoporosis-Induced Animal Model
Nutrients
bovine colostrum
bone
osteoporosis
supplementation
title Bovine Colostrum Supplementation Improves Bone Metabolism in an Osteoporosis-Induced Animal Model
title_full Bovine Colostrum Supplementation Improves Bone Metabolism in an Osteoporosis-Induced Animal Model
title_fullStr Bovine Colostrum Supplementation Improves Bone Metabolism in an Osteoporosis-Induced Animal Model
title_full_unstemmed Bovine Colostrum Supplementation Improves Bone Metabolism in an Osteoporosis-Induced Animal Model
title_short Bovine Colostrum Supplementation Improves Bone Metabolism in an Osteoporosis-Induced Animal Model
title_sort bovine colostrum supplementation improves bone metabolism in an osteoporosis induced animal model
topic bovine colostrum
bone
osteoporosis
supplementation
url https://www.mdpi.com/2072-6643/13/9/2981
work_keys_str_mv AT eirinikkydonaki bovinecolostrumsupplementationimprovesbonemetabolisminanosteoporosisinducedanimalmodel
AT laurafreitas bovinecolostrumsupplementationimprovesbonemetabolisminanosteoporosisinducedanimalmodel
AT brunomfonseca bovinecolostrumsupplementationimprovesbonemetabolisminanosteoporosisinducedanimalmodel
AT henriquereguengo bovinecolostrumsupplementationimprovesbonemetabolisminanosteoporosisinducedanimalmodel
AT carlosrapososimon bovinecolostrumsupplementationimprovesbonemetabolisminanosteoporosisinducedanimalmodel
AT anarbastos bovinecolostrumsupplementationimprovesbonemetabolisminanosteoporosisinducedanimalmodel
AT emanuelmfernandes bovinecolostrumsupplementationimprovesbonemetabolisminanosteoporosisinducedanimalmodel
AT raphaelfcanadas bovinecolostrumsupplementationimprovesbonemetabolisminanosteoporosisinducedanimalmodel
AT joaquimmigueloliveira bovinecolostrumsupplementationimprovesbonemetabolisminanosteoporosisinducedanimalmodel
AT vitormcorrelo bovinecolostrumsupplementationimprovesbonemetabolisminanosteoporosisinducedanimalmodel
AT ruilreis bovinecolostrumsupplementationimprovesbonemetabolisminanosteoporosisinducedanimalmodel
AT mariavliora bovinecolostrumsupplementationimprovesbonemetabolisminanosteoporosisinducedanimalmodel
AT parakevigkiata bovinecolostrumsupplementationimprovesbonemetabolisminanosteoporosisinducedanimalmodel
AT yianniskoutedakis bovinecolostrumsupplementationimprovesbonemetabolisminanosteoporosisinducedanimalmodel
AT georgiantina bovinecolostrumsupplementationimprovesbonemetabolisminanosteoporosisinducedanimalmodel
AT ruipinto bovinecolostrumsupplementationimprovesbonemetabolisminanosteoporosisinducedanimalmodel
AT andresecarrillo bovinecolostrumsupplementationimprovesbonemetabolisminanosteoporosisinducedanimalmodel
AT franklimmarques bovinecolostrumsupplementationimprovesbonemetabolisminanosteoporosisinducedanimalmodel
AT taniaamorim bovinecolostrumsupplementationimprovesbonemetabolisminanosteoporosisinducedanimalmodel